S&P 500 slips, but losses kept in check as Nvidia climbs ahead of results
ARLINGTON, Va. -On Thursday, Privia Health Group , Inc. (NASDAQ:PRVA) reported fourth-quarter results that beat analyst expectations, even as the company’s 2025 revenue guidance came in below consensus estimates.
The company’s shares fell -2.33% in pre-market trading.
The physician enablement company posted adjusted earnings per share of $0.21, surpassing the analyst estimate of $0.05. Revenue for the quarter reached $460.9 million, exceeding the consensus forecast of $420.94 million and representing a 4.6% increase from the same period last year.
For the full year 2024, Privia Health reported revenue of $1.74 billion, up 4.7% YoY. Adjusted EBITDA grew 25.2% to $90.5 million.
However, the company’s 2025 revenue guidance of $1.8-1.9 billion fell short of analysts’ expectations of $1.89 billion. Privia Health cited a challenging Medicare Advantage and value-based care environment as factors impacting its outlook.
The company ended 2024 with $491.1 million in cash and no debt. It generated $109.3 million in operating cash flow for the year, up 35.3% from 2023.
Privia Health expects to increase its implemented providers to 5,200-5,300 in 2025, representing 8.6-10.7% growth. The company also forecasts adjusted EBITDA of $105-110 million for 2025, up 16.1-21.6% YoY.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.